Salvianolic acid B can inhibit the TGF-β1-induced growth of A549 human non-small-cell lung cancer (NSCLC) cells by inactivating the phosphorylation of mitogen-activated protein kinase (MAPK) and Smad2/3. The gene discussed is WNK2; the disease is non-small cell lung carcinoma.